Skip to content
Open access

Hypertension-attributable mortality among older adult cancer survivors.

Oct 2026 · JCO Oncology Practice · 0 citations

TL;DR

Hypertension diagnosed after cancer diagnosis was associated with a notable proportion of all-cause mortality among older adult cancer survivors, with variation by cancer site and race and ethnicity.

Abstract

659 Background: Hypertension is a common and modifiable cardiovascular risk factor among cancer survivors. However, the burden of mortality attributable to hypertension developing after cancer diagnosis remains poorly understood. We therefore estimated the proportion of deaths attributable to incident hypertension among cancer survivors over 65 years of age and explored differences by race/ethnicity. Methods: Using SEER-Medicare data (2003-2020), we identified Medicare beneficiaries aged 66-85 diagnosed with invasive cancer between 2004 and 2019 and were free of hypertension before cancer diagnosis. Population attributable fractions (PAFs) for all-cause mortality associated with incident hypertension were estimated overall and by cancer site using Cox proportional hazards regression models adjusted for cancer stage, sex, race and ethnicity, comorbidities, diagnosis year, treatment types, and number of primary care visits (time-varying). Secondary analysis examined PAFs by race and ethnicity. Results: The cohort consisted of 393,474 cancer survivors who were free of hypertension at diagnosis. Overall, hypertension diagnosed after cancer diagnosis accounted for 4.5% (95% confidence interval [CI]: 4.1, 5.1) of all-cause mortality among cancer survivors. The highest adjusted PAFs were observed among survivors of prostate cancer (11.4%, 95% CI: 9.3, 13.7), female breast cancer (10.7%, 95% CI: 8.5, 13.4), multiple myeloma (9.2%, 95% CI: 5.2, 13.2), and kidney/renal pelvis cancer (7.4%, 95% CI: 2.0, 12.2). In contrast, PAFs were low for colorectal (0.8%, 95% CI: -0.9, 2.7) and ovarian (1.3%, 95% CI: -1.9, 4.3) cancers. The highest race-specific PAF was observed among non-Hispanic Black survivors (7%) followed by Non-Hispanic White survivors (5%), whereas Hispanic and non-Hispanic Asian/Pacific Islander survivors each had PAFs of 2%. Conclusions: Hypertension diagnosed after cancer diagnosis was associated with a notable proportion of all-cause mortality among older adult cancer survivors, with variation by cancer site and race and ethnicity. Efforts to improve hypertension detection, monitoring, and management in cancer survivors may reduce mortality and help address disparities in survivorship outcomes.

Read PDF

Similar papers

Open access Sep 2026

Excess hypertension-related mortality among cancer patients in the United States: a SEER-based study

Cancer remains a leading cause of mortality globally, while hypertension is the primary contributor to cardiovascular disease and premature death. These conditions frequently coexist; hypertension may precede cancer due to shared risk factors or arise during or after cancer treatment, partly as a result of the hyperten...

Bahaa Mali, Ali Mali, Alaa Mali et al. · 0 citations
Open access Sep 2026

Trends and disparities in breast cancer mortality among older adults in the United States, 1999–2020

Breast cancer mortality among older U.S. adults declined significantly between 1999 and 2020, but the increasing absolute number of deaths and persistent age, racial, ethnic, and geographic disparities indicate a continuing public health burden.

Tong Feng, Peng-Cheng Zheng, Qing-Yuan Li et al. · 0 citations
Open access Oct 2026

Assessment of cardiovascular disease-associated mortality risk among early-stage breast cancer patients

This is one of the first studies to identify an approximate mortality crossover point between CSM and BC-specific mortality at about 8 years (97 months) in women aged 70–85, providing a clinically relevant, exploratory time point for increased cardiovascular monitoring in this high-risk population.

Ndagijimana Djuma, E. Fiagbey, E. Iweh et al. · 0 citations
Oct 2026

Abstract C059: Sociodemographic patterns of racial disparities in cardiovascular disease mortality after breast cancer diagnosis by estrogen receptor status

Cardiovascular disease (CVD) is the leading non-cancer cause of death among breast cancer (BC) survivors. Although racial differences in CVD mortality after BC diagnosis are well documented, whether these patterns vary across sociodemographic factors and estrogen receptor (ER) status has not been well characteriz...

Xin-Yi Feng, L. Collin, M. Maliniak et al. · 0 citations
Oct 2026

Abstract A072: Racial and ethnic disparities in cardiovascular disease mortality among head and neck cancer survivors, 2000-2023

Elevated CVD mortality risk was observed for Black patients diagnosed with oral cavity and pharynx cancer and for White and Black patients with larynx cancer, and similar lower CVD mortality patterns were observed for Asian and Hispanic men and women across cancer sites.

J. Vo, Isha Patel, K. Taparra et al. · 0 citations
Oct 2026

Trends and disparities in cerebrovascular disease-related mortality involving colorectal cancer among older US adults: A nationwide retrospective analysis.

BACKGROUND Older adults with colorectal cancer (CRC) are at higher risk for cerebrovascular diseases (CeVD) due to shared risk factors and treatment effects. Despite CeVD being a leading global cause of death, its mortality burden in older CRC patients in the US remains underexplored. METHODS We analyzed CDC WONDER m...

Sufyan Shahid, Z. Ejaz, Shahzaib Ahmed et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.